gain more revenue from these new distribution channels and also resulted to more efficient cost of sales management. However, the company had increasing financial costs from short-term loans from other
subsidiaries have contract revenues for Q3/2017 162 Million Baht which is decrease of 39 Million Baht (19%) from Q3/2016 contract revenues. Q3/2017’s net profit of 5 Million Baht represents increasing of 4
baht which increase 281.83 million baht or 25%. Due to increasing of project operation. 2. Other Income as 8.42 million baht by compared with the 10.97 million bath was decrease 2.55 million baht or (23
deducted by an allowance for doubtful account of Baht 0.03 million, resulted in the record of the net profit of the Company and its subsidiary for the year 2017 of Baht 12.52 million, increasing by Baht
products at competitive prices and higher export value. Gross margin were Baht 5.09 million or 11.33 % in 2017 increasing from Baht 1.72 million or 8.90% for the same period in 2016. On June 15, 2016, the
420,284,565.87 Baht or 37.62%. This resulted from the amount of orders increased. The cost of sales in year 2018 was 1,349,555,652.00 Baht, representing 87.77% of total sales. The reasons were the increasing of
medical treatments when compared to income from medical treatments went up 1.94% from CMR a subsidiary went up 3.73% due to expending employment increase and depreciation of building is increasing. The cost
lower other incomes; consequently, loss was Baht 2.30 million higher in 2018 even the gross margin was better. Gross margin were Baht 6.13 million or 17.97 % in 2018 increasing from Baht 5.09 million or
, the Board of Directors have approved the increasing of SBLC facility amount via email on 28 March 2019 and then the Company had entered into the amendment of credit facility agreement on 1 April 2019
increased 7.31%, it increased in portion of increasing revenue but expenses were at the same level as last year and finance cost decreased 14.18% from last year from liability decreased too. The Company had